Marc Since

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Pharmaceuticals (Basel, Switzerland)

Expert opinion on drug discovery

International journal of molecular sciences

Molecules (Basel, Switzerland)

Centre d'Etudes et de Recherche sur le Médicament de Normandie

Institut de Chimie Radicalaire (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre d'Etudes et de Recherche sur le Médicament de Normandie Sep 01 2012

France

Lecturer, Dr :: Analytical chemistry

Centre d'Etudes et de Recherche sur le Médicament de Normandie

France

assitant researcher and teacher, Dr :: Analytical chemistry

Aix-Marseille Université Faculté de Pharmacie

France

Assistant researcher and teacher :: Analytical chemistry

Education History

Institut de Chimie Radicalaire Sep 01 2007 - Aug 31 2011

France

PHD :: Laboratoire de Pharmacochimie Radicalaire

Aix-Marseille Université

France

MSC :: ICR, Equipe Pharmacochimie Radicalaire

Publications

Thomas Lemaitre, Marie Cornu, Florian Schwalen, Marc Since, Charline Kieffer, Anne-Sophie Voisin-Chiret
Molecular glue degraders: exciting opportunities for novel drug discovery. Expert opinion on drug discovery 19 (4) (2024)
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, Caroline Castera-Ducros, Sandra Carvalho, Susan Wyllie, Mohamed Lotfi Efrit, Dimitri Fayolle, Marc Since, Patrice Vanelle, Pierre Verhaeghe, Nadine Azas, Hussein El-Kashef
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, Caroline Castera-Ducros, Sandra Carvalho, Susan Wyllie, Mohamed Lotfi Efrit, Dimitri Fayolle, Marc Since, Patrice Vanelle, Pierre Verhaeghe, Nadine Azas, Hussein El-Kashef
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, Caroline Castera-Ducros, Sandra Carvalho, Susan Wyllie, Mohamed Lotfi Efrit, Dimitri Fayolle, Marc Since, Patrice Vanelle, Pierre Verhaeghe, Nadine Azas, Hussein El-Kashef
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Thomas Lemaitre, Marie Cornu, Florian Schwalen, Marc Since, Charline Kieffer, Anne-Sophie Voisin-Chiret
Molecular glue degraders: exciting opportunities for novel drug discovery. Expert opinion on drug discovery 19 (4) (2024)
Thomas Lemaitre, Marie Cornu, Florian Schwalen, Marc Since, Charline Kieffer, Anne-Sophie Voisin-Chiret
Molecular glue degraders: exciting opportunities for novel drug discovery. Expert opinion on drug discovery (2024)
Willy Smeralda, Marc Since, Sophie Corvaisier, Dimitri Fayolle, Julien Cardin, Sylvain Duprey, Jean-Pierre Jourdan, Christophe Cullin, Aurélie Malzert-Freon
A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs. International journal of molecular sciences 24 (23) (2023)
Romain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, Sébastien Hutter, Alix Sournia-Saquet, Clotilde Boudot, Emilie Brenot, Caroline Castera-Ducros, Sophie Corvaisier, Marc Since, Aurélie Malzert-Freon, Bertrand Courtioux, Alexis Valentin, Pierre Verhaeghe, Nadine Azas, Pascal Rathelot, Patrice Vanelle
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2- a ]pyridine Antileishmanial Pharmacophore. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
François-Xavier Toublet, Cédric Lecoutey, Julien Lalut, Bérénice Hatat, Audrey Davis, Marc Since, Sophie Corvaisier, Thomas Freret, Jana Sopkova de Oliveira Santos, Sylvie Claeysen, Michel Boulouard, Patrick Dallemagne, Christophe Rochais
Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease. Molecules (Basel, Switzerland) 24 (15) (2019)

Marc Since.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marc Since